EBITDA: Income before interest, taxes, depreciation and amortization.
Bright Minds Biosciences Inc. (DRUG) had EBITDA of $-2.37M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.79M |
|
-- |
|
-- |
|
$2.38M |
|
$-2.38M |
|
$-1.41M |
|
$-3.79M |
|
$-3.79M |
|
$-3.79M |
|
$-3.79M |
|
$-3.79M |
|
$-3.79M |
|
$-2.38M |
|
|
EBITDA |
$-2.37M |
7.08M |
|
7.08M |
|
$-0.54 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$37.86M |
|
-- |
|
$0.09M |
|
$37.96M |
|
$0.44M |
|
$0.05M |
|
$0.05M |
|
$0.48M |
|
$37.47M |
|
$37.47M |
|
$37.47M |
|
7.08M |
|
| Cash Flow Statement Financials | |
$-5.37M |
|
-- |
|
$37.78M |
|
$4.14M |
|
$37.15M |
|
$33.02M |
|
$1.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
86.56 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.12% |
|
-10.12% |
|
-9.99% |
|
-10.10% |
|
$5.29 |
|
$-0.76 |
|
$-0.76 |
|